These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
739 related articles for article (PubMed ID: 31698633)
1. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics. Ni KW; Sun GZ Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633 [TBL] [Abstract][Full Text] [Related]
2. The identification of a common different gene expression signature in patients with colorectal cancer. Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244 [TBL] [Abstract][Full Text] [Related]
3. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma. Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
6. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis. Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972 [TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis of microarray data from the GEO database to identify the candidate genes linked to poor prognosis in lung adenocarcinoma. Liu X; Li L; Xie X; Zhuang D; Hu C Technol Health Care; 2023; 31(2):579-592. PubMed ID: 36336945 [TBL] [Abstract][Full Text] [Related]
8. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases. Yu Y; Tian X Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511 [TBL] [Abstract][Full Text] [Related]
9. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis. Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889 [TBL] [Abstract][Full Text] [Related]
10. Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma. Fei H; Chen S; Xu C Biomed Res Int; 2020; 2020():8931419. PubMed ID: 33062704 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
12. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics. Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339 [TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma. Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504 [TBL] [Abstract][Full Text] [Related]
14. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis. Dai JJ; Zhou WB; Wang B Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397 [TBL] [Abstract][Full Text] [Related]
15. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples. Dong S; Men W; Yang S; Xu S Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809 [TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway. Li Z; Zhang Y; Zhou Y; Wang F; Yin C; Ding L; Zhang S Sci Rep; 2021 Dec; 11(1):23681. PubMed ID: 34880385 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment. Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038 [TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics. Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024 [TBL] [Abstract][Full Text] [Related]
19. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis. Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311 [TBL] [Abstract][Full Text] [Related]
20. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]